Gsa Capital Partners LLP Novo Nordisk A S Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$69.3 - $90.95 $921,204 - $1.21 Million	13,293 New	13,293 $923,000
Q3 2020 Nov 06, 2020	SELL	$63.69 - $70.22 $234,888 - $258,971	-3,688 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$58.54 - $67.94 $215,895 - $250,562	3,688 New	3,688 $241,000
Q4 2018 Feb 12, 2019	SELL	$41.54 - $47.25 $204,293 - $232,375	-4,918 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$46.76 - $51.24 $229,965 - $251,998	4,918 New	4,918 $232,000

1,684

304M

25.9M

43.8M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.